Pharmaceuticals - MoldNewsHub

Stopping Fungi at the Molecular Level: How Caspofungin Blocks Cell-Wall Construction

Scientific visualization of a fungal cell with a structured teal cell wall and glowing amber interior, representing cell-wall integrity and its disruption by antifungal treatment

Caspofungin stops fungal infections by trapping a glucan chain mid-construction inside the Fks1 enzyme — blocking cell-wall assembly at the exact moment it occurs. New structural research reveals how this works, and why certain mutations allow fungi to escape it.

DNA sequencing data visualization on a dark screen showing genomic comparison of fungal pathogen strains

Reading the Fungal Genome: How Comparative Genomics Helps Predict the Next Pathogen Threat

Fungi evolve continuously — and their genomes record every adaptation, resistance event, and ecological shift. Comparative genomics is giving researchers a way to read those records before the next outbreak becomes visible.

Industrial bioreactor vessel with fungal culture growing inside, laboratory setting with soft blue lighting

Living Factories: Why Scaling Fungal Drug Production Is More About Physics Than Biology

Engineering fungi to produce psilocybin is possible. Scaling that production to industrial levels is where biology runs into physics — and where the real engineering challenge begins.

Close-up microscope view of fungal cells or hyphae in clinical or laboratory setting, muted tones

The Rising Threat: Drug-Resistant Fungi and the Expanding Frontier of Infection

Drug-resistant fungi are an expanding concern in global healthcare — harder to treat, harder to detect, and increasingly capable of surviving in the environments built to contain them. Here is what is driving the shift.

Microscopy-style render of fungal spore clusters in blue-grey tones against dark background

When Infection Meets Reality: What Clinical Evidence Reveals About the Growing Challenge of Fungal Disease

Fungal infections kill more people than malaria each year — yet remain under-prioritized in clinical practice. Here's what the evidence shows about why, and what it will take to close the gap.

Candida albicans fungal cells under microscopy showing rapid adaptation during infection and antifungal resistance development in immunocompromised patients

When Fungi Refuse to Stay Still: How Rapid Adaptation in Infection Is Reshaping Medical Risk

A fungal infection diagnosed today may not be the same infection by next week. New research reveals that certain fungi can adapt within the human body in days — shifting their metabolism, growth, and drug sensitivity as they go.

Aspergillus fumigatus spores under microscopy showing fungal sensitization leading to ABPA diagnosis through IgE blood testing

Listening Beyond the Surface: How Modern Diagnostics Are Reshaping the Detection of Aspergillus Sensitization and ABPA

Every breath carries Aspergillus spores. For most people, the immune system dismisses them silently. For some, it remembers — and that memory becomes the hardest disease to detect in time.

Mold News Aspergillus Immunity Research

Metabolic Hijack: How Aspergillus fumigatus Rewires Immunity from the Inside Out

Aspergillus fumigatus doesn’t just evade immunity — it rewires immune cell metabolism, turning the body’s defenses into silent bystanders.

Mold News Peptide Plant Defense

The Peptide That Saves Plants from Mold Toxins

A tiny peptide may hold the key to protecting crops from devastating mold toxins, revealing a hidden survival signal inside plant cells.

Mold News Health Mycotoxin Research

The Mold Gap in One Health

Mycotoxins remain overlooked in One Health, despite shaping food safety, climate risk, and long-term human and agricultural health.

Input your search keywords and press Enter.